Funding for this research was provided by:
AstraZeneca (Not applicable)
Received: 17 October 2019
Accepted: 9 June 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: This was a post hoc analysis of five clinical trials; the original study protocols were approved by local institutional review boards and ethics committees, and conducted in accordance with the Declaration of Helsinki, International Conference on Harmonization/Good Clinical Practice, and applicable local regulations. All patients provided their consent.
: Not applicable.
: At the time this work was conducted AK, RP, SR, UGE, and AJ were employees of AstraZeneca. VR has no conflicts of interest to declare.